ABDX- Flowing downhill PRES- Streaming up RDT- Ai Transformer Abingdon Health 8.75p £16.58m (ABDX.L) Final’s to June 2024 reported revenue grew 52% to £6.1m, with gross margins improving to 60% from 51%. The adjusted EBITDA loss of £1.1m is a significant improvement from last year’s £2.9m loss. The report included a month of the £0.7m IVDeology acquisition made in May as well as the cost of a new commercial office /laboratory opening shortly in the US . ABDX is a lateral flow contract research (...
* A corporate client of Hybridan LLP ** Potential means Intention to Float (ITF) has been announced, or it is a rumour ***Arranged by type of listing and date of announcement ****Alphabetically arranged Share prices and market capitalisations taken from the current price on the day of publication Dish of the day Admissions: None Delistings: Ascential (ASCL.L) delisted from AIM. What’s baking in the oven? ITF announced:*** Potential** Initial Public Offerings: 30th September 2024: Applied Nutriti...
25th January 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obje...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.